跳至主要内容
临床试验/CTRI/2022/07/044186
CTRI/2022/07/044186招募中4 期

Efficacy of Shirothalam (Kachuradi Churnam and Ksheerabala 101) and Padabhyangam (Ksheerabala Thailam) as an add-on therapy to standard of care in insomnia among patients undergoing chemotherapy: A non-randomized active control-group study.

Dr Arathi P0 个研究点目标入组 0 人开始时间: 待定最近更新:

试验速览

阶段
4 期
状态
招募中
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • 1) Aged 18 years â?? 60 years with no discrimination of sex, religion, gender and economic status
  • 2) Cancer patients undergoing chemotherapy, diagnosed with insomnia as per DSM V with an ISI
  • score of 15-21 (Clinical Insomnia with moderate severity) and 22-28 (clinical insomnia severe).
  • 3) Life expectancy >3 months.
  • 4) Those who are willing to participate in this study and sign informed consent forms.

排除标准

  • 1. Cancer patients undergoing chemo-radiation
  • 2. Cancer patients planned for minor or major surgery
  • 3. Cancer patients with abnormal cognition and speech causing difficulty in comprehension, and
  • expression.

研究者

发起方
Dr Arathi P

相似试验